Senior Counsel – Biotech Patent Law - Biosimilars
Amgen
Summary
In this vital role you will develop, implement and execute a market access strategy for Amgen's biosimilar and/or innovator molecules, including freedom-to-operate analyses for drug substance, drug product, formulations, processes, and methods of treatment.
Job description
What you will do
In this vital role you will develop, implement and execute a market access strategy for Amgen's biosimilar and/or innovator molecules, including freedom-to-operate analyses for drug substance, drug product, formulations, processes, and methods of treatment.
Key Responsibilities
- Handling all aspects of intellectual property, especially in identification of relevant patents, conducting searches for prior art, analyzing third party patents, developing persuasive legal arguments, drafting opinions, working with experts, and performing other pre-litigation activities
- Developing and implementing global freedom-to-operate strategies for Amgen products in collaboration with other in-house attorneys
- Drafting and prosecuting patent applications and providing patent litigation support
- Developing and counseling others on intellectual property strategies associated with Amgen's business and research endeavors
- Working individually, in legal teams, and in cross-functional business teams
- 10% domestic and global travel anticipated
This role may be remote or may include hybrid work based at one of our sites in Thousand Oaks, CA; San Francisco, CA; or Cambridge, MA. The role requires the ability to work client group hours.
Requirements
- J.D. degree or LL.M. degree from an accredited law school
- Admission to practice law in a U.S. jurisdiction
- Four (4) years of experience practicing intellectual property law
- Registration to practice before the U.S. Patent and Trademark Office
- 7+ years of experience practicing patent or intellectual property law (preferred)
- Experience in U.S. and/or foreign intellectual property law relating to biotechnology at a law firm or biotechnology/pharmaceutical corporation (preferred)
- Experience in U.S. and/or foreign adversarial proceedings such as patent litigation, Inter Partes Reviews, Post Grant Reviews, or oppositions (preferred)
- Experience developing and implementing a global freedom-to-operate strategy (preferred)
- Undergraduate degree in the sciences with working understanding of molecular biology, cell biology, microbiology, biochemistry, genetics, immunology, structural biology, pharmaceutics, or chemical engineering (preferred)
- Advanced degree such as Master's or Ph.D. or research experience in a science area (preferred)
- Excellent judgement, analytical skills, legal drafting and oral and written communication skills
- Strong management and client counseling skills
- Ability to work independently and in teams, navigate ambiguity, prioritize workflow, and manage multifaceted projects in a fast-paced environment
Benefits
- Retirement and Savings Plan
- Medical, Dental & Vision
- Life and Disability Insurance
- Flexible Spending Accounts
- Discretionary Annual Bonus
- Stock-Based Long-Term Incentives
- Award-Winning Time-Off Plans
- Flexible Work Models
Company overview
Amgen Inc. is a leading American multinational biopharmaceutical company headquartered in Thousand Oaks, California, founded in 1980. As one of the world's largest independent biotechnology companies, Amgen specializes in discovering, developing, manufacturing, and delivering innovative human therapeutics. The company focuses on six key therapeutic areas: inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience. Amgen's portfolio includes blockbuster drugs such as Enbrel for autoimmune diseases, Prolia and XGEVA for osteoporosis, Repatha for cholesterol management, Otezla for psoriasis, and Neulasta for chemotherapy-induced neutropenia. With approximately 28,000 employees worldwide, Amgen operates as a component of both the Dow Jones Industrial Average and Nasdaq-100 indices. The company maintains a robust research and development pipeline with numerous clinical programs across various stages, leveraging cutting-edge biotechnology and human genetic data to address some of the world's most challenging diseases. Amgen's manufacturing capabilities span multiple global locations, and it distributes products through pharmaceutical wholesale distributors and direct-to-consumer channels.